Sabel M - Search Results

1

Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer.

Li W, Tanikawa T, Kryczek I, Xia H, Li G, Wu K, Wei S, Zhao L, Vatan L, Wen B, Shu P, Sun D, Kleer C, Wicha M, Sabel M, Tao K, Wang G, Zou W. Li W, et al. Among authors: sabel m. Cell Metab. 2018 Jul 3;28(1):87-103.e6. doi: 10.1016/j.cmet.2018.04.022. Epub 2018 May 24. Cell Metab. 2018. PMID: 29805099 Free PMC article.

2

Sentinel node biopsy prior to neoadjuvant chemotherapy.

Sabel MS, Schott AF, Kleer CG, Merajver S, Cimmino VM, Diehl KM, Hayes DF, Chang AE, Pierce LJ. Sabel MS, et al. Am J Surg. 2003 Aug;186(2):102-5. doi: 10.1016/s0002-9610(03)00168-5. Am J Surg. 2003. PMID: 12885598

3

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells.

Kleer CG, Cao Q, Varambally S, Shen R, Ota I, Tomlins SA, Ghosh D, Sewalt RG, Otte AP, Hayes DF, Sabel MS, Livant D, Weiss SJ, Rubin MA, Chinnaiyan AM. Kleer CG, et al. Among authors: sabel ms. Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11606-11. doi: 10.1073/pnas.1933744100. Epub 2003 Sep 19. Proc Natl Acad Sci U S A. 2003. PMID: 14500907 Free PMC article.

4

Small (< 2.0-cm) breast cancers: mammographic and US findings at US-guided cryoablation--initial experience.

Roubidoux MA, Sabel MS, Bailey JE, Kleer CG, Klein KA, Helvie MA. Roubidoux MA, et al. Radiology. 2004 Dec;233(3):857-67. doi: 10.1148/radiol.2333031734. Radiology. 2004. PMID: 15567802 Clinical Trial.

5

Comprehensive axillary evaluation in neoadjuvant chemotherapy patients with ultrasonography and sentinel lymph node biopsy.

Khan A, Sabel MS, Nees A, Diehl KM, Cimmino VM, Kleer CG, Schott AF, Hayes DF, Chang AE, Newman LA. Khan A, et al. Among authors: sabel ms. Ann Surg Oncol. 2005 Sep;12(9):697-704. doi: 10.1245/ASO.2005.09.007. Epub 2005 Aug 4. Ann Surg Oncol. 2005. PMID: 16079956 Free article.

6

Protein kinase C epsilon is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy.

Pan Q, Bao LW, Kleer CG, Sabel MS, Griffith KA, Teknos TN, Merajver SD. Pan Q, et al. Cancer Res. 2005 Sep 15;65(18):8366-71. doi: 10.1158/0008-5472.CAN-05-0553. Cancer Res. 2005. PMID: 16166314

7

RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast.

Kleer CG, Griffith KA, Sabel MS, Gallagher G, van Golen KL, Wu ZF, Merajver SD. Kleer CG, et al. Breast Cancer Res Treat. 2005 Sep;93(2):101-10. doi: 10.1007/s10549-005-4170-6. Breast Cancer Res Treat. 2005. PMID: 16187229 Free article.

8

Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis.

Mehra R, Varambally S, Ding L, Shen R, Sabel MS, Ghosh D, Chinnaiyan AM, Kleer CG. Mehra R, et al. Among authors: sabel ms. Cancer Res. 2005 Dec 15;65(24):11259-64. doi: 10.1158/0008-5472.CAN-05-2495. Cancer Res. 2005. PMID: 16357129

9

A putative role for psoriasin in breast tumor progression.

Krop I, März A, Carlsson H, Li X, Bloushtain-Qimron N, Hu M, Gelman R, Sabel MS, Schnitt S, Ramaswamy S, Kleer CG, Enerbäck C, Polyak K. Krop I, et al. Among authors: sabel ms. Cancer Res. 2005 Dec 15;65(24):11326-34. doi: 10.1158/0008-5472.CAN-05-1523. Cancer Res. 2005. PMID: 16357139

10

Does the method of biopsy affect the incidence of sentinel lymph node metastases?

Newman EL, Kahn A, Diehl KM, Cimmino VM, Kleer CA, Chang AE, Newman LA, Sabel MS. Newman EL, et al. Among authors: sabel ms. Breast J. 2006 Jan-Feb;12(1):53-7. doi: 10.1111/j.1075-122X.2006.00179.x. Breast J. 2006. PMID: 16409587 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

472 results

Search Page

Filters